Dr. Gavin Smith, of St. Jude CEIRS, discussed his recent COVID-19 research at Duke-NUS in Singapore. His group identified a variant of the SARS-CoV-2 virus that causes milder infections compared to the original virus. They found that patients infected with this variant had lower frequency of ICU admittance. Dr. Smith’s group also found that immune responses to this variant were more robust, a finding that could contribute to COVID-19 vaccine and treatment development.
The article discussing these findings can be read in full on the Reuters website.